MetLife Investment Management’s Steris STE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.72M | Sell |
22,433
-483
| -2% | -$104K | 0.02% | 670 |
|
|
2026
Q1 | $5.07M | Sell |
22,916
-612
| -3% | -$150K | 0.03% | 613 |
|
|
2025
Q4 | $5.96M | Sell |
23,528
-904
| -4% | -$227K | 0.03% | 546 |
|
|
2025
Q3 | $6.05M | Sell |
24,432
-602
| -2% | -$144K | 0.03% | 551 |
|
|
2025
Q2 | $6.01M | Sell |
25,034
-488
| -2% | -$114K | 0.04% | 501 |
|
|
2025
Q1 | $5.78M | Sell |
25,522
-599
| -2% | -$132K | 0.03% | 541 |
|
|
2024
Q4 | $5.37M | Buy |
26,121
+480
| +2% | +$105K | 0.03% | 517 |
|
|
2024
Q3 | $6.22M | Sell |
25,641
-710
| -3% | -$166K | 0.04% | 423 |
|
|
2024
Q2 | $5.79M | Buy |
26,351
+3,209
| +14% | +$697K | 0.03% | 420 |
|
|
2024
Q1 | $5.2M | Sell |
23,142
-849
| -4% | -$191K | 0.04% | 465 |
|
|
2023
Q4 | $5.27M | Buy |
23,991
+23,770
| +10,756% | +$5.03M | 0.04% | 424 |
|
|
2023
Q3 | $48.5K | Sell |
221
-24,976
| -99% | -$5.65M | ﹤0.01% | 2835 |
|
|
2023
Q2 | $5.67M | Sell |
25,197
-434
| -2% | -$86.8K | 0.04% | 378 |
|
|
2023
Q1 | $4.9M | Sell |
25,631
-438
| -2% | -$84.7K | 0.04% | 459 |
|
|
2022
Q4 | $4.81M | Sell |
26,069
-473
| -2% | -$83.2K | 0.04% | 456 |
|
|
2022
Q3 | $4.41M | Sell |
26,542
-117
| -0.4% | -$23.8K | 0.04% | 473 |
|
|
2022
Q2 | $5.5M | Sell |
26,659
-809
| -3% | -$182K | 0.04% | 370 |
|
|
2022
Q1 | $6.64M | Buy |
27,468
+5,369
| +24% | +$1.24M | 0.04% | 368 |
|
|
2021
Q4 | $5.38M | Sell |
22,099
-432
| -2% | -$98.7K | 0.04% | 369 |
|
|
2021
Q3 | $4.6M | Sell |
22,531
-106
| -0.5% | -$22.7K | 0.04% | 410 |
|
|
2021
Q2 | $4.67M | Buy |
22,637
+2,298
| +11% | +$463K | 0.04% | 422 |
|
|
2021
Q1 | $3.87M | Sell |
20,339
-382
| -2% | -$70.9K | 0.04% | 521 |
|
|
2020
Q4 | $3.93M | Sell |
20,721
-843
| -4% | -$157K | 0.04% | 469 |
|
|
2020
Q3 | $3.8M | Sell |
21,564
-653
| -3% | -$104K | 0.04% | 419 |
|
|
2020
Q2 | $3.41M | Buy |
22,217
+363
| +2% | +$55.3K | 0.04% | 469 |
|
|
2020
Q1 | $3.06M | Sell |
21,854
-668
| -3% | -$99.9K | 0.04% | 425 |
|
|
2019
Q4 | $3.43M | Sell |
22,522
-26,734
| -54% | -$3.92M | 0.04% | 562 |
|
|
2019
Q3 | $7.12M | Sell |
49,256
-838
| -2% | -$125K | 0.08% | 231 |
|
|
2019
Q2 | $7.46M | Sell |
50,094
-1,468
| -3% | -$196K | 0.08% | 220 |
|
|
2019
Q1 | $6.6M | Buy |
51,562
+38
| +0.1% | +$4.47K | 0.07% | 240 |
|
|
2018
Q4 | $5.51M | Sell |
51,524
-240
| -0.5% | -$26.8K | 0.07% | 262 |
|
|
2018
Q3 | $5.92M | Buy |
+51,764
| New | +$5.85M | 0.06% | 295 |
|
Other funds holding STE
OAG
GIM
MetLife Investment Management's STE Position: Q2 2026 in Review
MetLife Investment Management reduced its Steris (STE) stake by 2.1% in Q2 2026, selling an estimated $104K and leaving 22,433 shares worth $4.72M. The position accounts for 0.02% of the portfolio, ranked #670.
MetLife Investment Management first reported a position in STE in Q3 2018 and has held it in 32 quarters since. The position peaked at $7.46M in Q2 2019. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- MetLife Investment Management held 22,433 shares of Steris worth $4.72M as of Q2 2026.
- MetLife Investment Management sold 483 Steris shares in Q2 2026, an estimated $104K.
- Steris made up 0.02% of MetLife Investment Management's portfolio in Q2 2026, its #670 holding.
- MetLife Investment Management first reported a position in Steris in Q3 2018 and has held it in 32 quarters since.
- MetLife Investment Management's Steris position peaked at $7.46M in Q2 2019.
- 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.